Name: 글로벌 시장 동향
SKU: PH7769
Availability: InStock

보고서 요약(국문)

개요
전 세계 색소 병변 치료 시장은 2022년 XX억 달러에 달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률로 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.

색소 병변 치료는 피부의 비정상적인 색소 침착을 해결하기 위해 고안된 다양한 의학적 및 미용적 시술을 의미합니다. 피부의 색소 침착은 주로 피부, 모발, 눈 색깔을 결정하는 색소인 멜라닌의 존재와 분포에 의해 결정됩니다. 색소 병변은 피부에 어둡거나 밝은 부위로 나타날 수 있습니다.
색소 병변은 종종 멜라닌과 관련되어 피부의 작은 부위 또는 넓은 부위가 갈색, 검은색 또는 파란색으로 보이게 합니다. 색소 병변은 대부분 멜라닌 세포성입니다. 그러나 특히 피부색이 어두운 사람에게서는 비멜라닌 세포성 병변도 색소 침착을 보일 수 있습니다.

시장 동향
제품 출시 증가
색소 병변 치료 분야의 제품 출시가 증가하면서 시장 성장이 크게 촉진되고 있습니다. 색소 병변은 과색소침착 또는 저색소침착 부위를 포함하며, 햇볕 손상, 검버섯, 주근깨, 모반, 기미, 특정 유형의 피부 병변 등 다양한 원인으로 발생할 수 있습니다.
예를 들어, 2023년 11월 Justera Health Ltd.는 CUTERA XEO를 출시하여 프리미엄 레이저 치료 서비스를 확대했습니다. XEO는 피부 재생 및 표면 개선, 색소 병변, 혈관 병변, 제모를 위해 설계된 프리미엄 레이저 플랫폼입니다.
또한, 2023년 7월 El.En. 그룹의 자회사인 DEKA는 레이저 및 마이크로파 장비를 기반으로 하는 새로운 "PRO" 라인을 출시했습니다. 이 제품 역시 혈관 치료, 표피 색소 병변, 피부 재생에 최적화되어 있습니다.

또한, 2022년 6월, 시노슈어(Cynosure)는 모든 피부 타입에 안전하고 효과적인 색소침착 치료 및 피부 재생을 위한 피코슈어 프로(PicoSure Pro) 기기를 출시했습니다. 피코슈어 프로 기기는 755nm 에너지를 피코초 단위로 전달할 수 있는 독보적인 성능을 자랑합니다.
더불어, 색소 질환의 유병률 증가와 치료 기기의 기술 발전과 같은 주요 성장 동력이 향후 시장 성장을 견인할 것으로 예상됩니다.
레이저 치료 관련 부작용
레이저 치료는 피부 표면 재생 및 색소 감소에 도움이 됩니다. 경우에 따라 치료 부위의 색소 변화가 나타날 수 있으며, 해당 부위가 어두워지거나 밝아질 수 있습니다. 또한, 특히 강도 높은 레이저 치료 후에는 멍이 드는 경우가 발생할 수 있습니다.
세분화 분석
전 세계 색소 병변 치료 시장은 병변 유형, 제품 유형, 최종 사용자 및 지역별로 세분화됩니다.

레이저 및 에너지 기반 기기 부문은 시장 점유율의 약 62.5%를 차지했습니다.
레이저 및 에너지 기반 기기 부문은 제품 승인 건수 증가로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 레이저 및 에너지 기반 기기는 다양한 피부 치료를 위해 피부과 및 미용 시술에 널리 사용됩니다. 고주파(RF) 에너지는 피부의 심층부를 가열하여 콜라겐 재생을 촉진하고 피부 탄력을 개선하는 데 사용됩니다.
예를 들어, 2022년 LASEROPTEK Co., Ltd.는 피부과 및 일반 외과에서 사용되는 HELIOS IV-785 레이저 시스템에 대해 미국 식품의약국(FDA) 510(k) 승인을 받았습니다. 이 시스템은 피부 톤 개선, 미백, 양성 색소 및 혈관 병변 제거, 다색 문신 제거에 사용됩니다.

또한, 2023년 3월 미국 식품의약국(FDA)은 캔델라 코퍼레이션(Candela Corporation)의 피코웨이(PicoWay) 레이저를 카페오레, 검버섯, 기미 치료에 승인했습니다. 이 레이저 시스템은 여드름 흉터, 양성 색소 병변, 문신 제거, 주름 등 여러 적응증에 대해 승인되었습니다. 따라서 위와 같은 요인으로 인해 해당 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
지역 분석
북미는 전 세계 색소 병변 치료 시장에서 상당한 비중을 차지할 것으로 예상됩니다.
전 세계 색소 병변 치료 시장은 북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카로 구분됩니다.
북미는 미용 수술 증가, 색소 질환 유병률 증가, 의료비 지출 증가 등의 요인으로 인해 상당한 시장 점유율을 유지해 왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 미용학회(Aesthetics Society)에 따르면 미용 수술은 54%, 비수술적 시술은 44% 증가했습니다. 2021년 미국에서 평균적인 성형외과 의사는 320건의 수술을 시행했습니다.
또한, 미국 국립보건원(NIH)에 따르면 성인 백반증의 유병률은 0.76%(190만 건)에서 1.11%(280만 건) 사이로 추정됩니다. 더불어, 이 연구는 미국 성인 백반증 환자의 약 40%가 진단받지 못했을 가능성이 있다고 제시합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 색소 병변 치료 시장에 상당한 영향을 미쳤습니다. 2020년 초 팬데믹 발생으로 광범위한 봉쇄와 제한 조치가 시행되면서 전 세계적으로 정기적인 진단, 치료, 신약 출시 및 상담에 차질이 생겼습니다. 팬데믹으로 인해 많은 제약 회사나 의료기기 제조업체는 인력 부족에 직면했고, 봉쇄 조치로 인해 직원들이 출근하지 못하는 상황이 발생했습니다. 따라서 이러한 요인들로 인해 색소 병변 치료 시장은 예측 기간 동안 다소 영향을 받을 것으로 예상됩니다.

시장 세분화
병변 유형별
• 주근깨
• 검버섯
• 기미
• 기타
제품 유형별
• 레이저 및 에너지 기반 기기
• RF 기기
• 초음파 기기
• 기타
최종 사용자별
• 피부과 클리닉
• 병원
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Alma Lasers Ltd, Cutera Inc., Cynosure Inc., Lumenis Be Ltd., Lutronic Corporation, Lynton Lasers Ltd, Bausch Health, Fotona, Asclepion Laser Technologies 등이 있습니다. Candela Corporation을 비롯한 여러 기업.
주요 동향
• 2021년 4월, Cynosure는 MyEllevate Surgical Suture System을 인수하여 최소 침습 안면 회춘 솔루션 포트폴리오를 확장했습니다.
보고서 구매 이유

• 병변 유형, 제품 유형, 최종 사용자 및 지역별 글로벌 색소 병변 치료 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위해.

• 모든 세그먼트를 포함한 글로벌 색소 병변 치료 시장의 다양한 데이터가 담긴 Excel 데이터 시트.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일 제공.

글로벌 색소 병변 치료 시장 보고서는 약 58개의 표, 58개의 그림, 185페이지로 구성됩니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Pigmented Lesion Treatment Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Pigmented lesion treatment refers to the various medical and aesthetic procedures designed to address abnormal pigmentation on the skin. Pigmentation in the skin is primarily determined by the presence and distribution of melanin, the pigment responsible for skin, hair, and eye color. Pigmented lesions can manifest as darker or lighter areas on the skin.
Pigmented lesions often involve melanin that results in small or large areas of the skin appearing brown, black, or even blue. Pigmented skin lesions are most often melanocytic. However, non-melanocytic lesions can also be pigmented, particularly in dark-skinned individuals.
Market Dynamics
Increasing product launches
The increasing product launches for pigmented lesion treatment act as a significant driver for market growth. Pigmented lesions can include areas of hyperpigmentation or hypopigmentation and can result from conditions such as sun damage, age spots, freckles, birthmarks, melasma, and certain types of skin lesions.
For instance, in November 2023, Justera Health Ltd. launched an extended range of premium laser treatment services with CUTERA XEO. XEO is a premium laser platform designed for skin revitalization and resurfacing, pigmented lesions, vascular lesions, and hair removal.
Additionally, in July 2023, DEKA, a subsidiary of the El.En. Group launch of its new “PRO” line, based on laser and microwave devices. It is also strongly optimized for vascular treatments, superficial pigmented lesions, and skin rejuvenation.
Also, in June 2022, Cynosure launched the PicoSure Pro device for safe and effective treatments for unwanted pigmentation and skin revitalization for all skin types. The PicoSure Pro device can uniquely deliver 755nm energy in picoseconds.
Furthermore, significant growth drivers such as the rising prevalence of pigmentation disorders, and technological advancements in treatment devices are expected to drive the market in the forecast period.
Side effects associated with laser treatments
Laser treatment helps in skin resurfacing and pigmentation reduction. In some cases, a person can experience changes to the pigmentation of the treated area, including the darkening or lightening of the area. Also, some individuals can experience bruising, especially after more aggressive laser treatments.
Segment Analysis
The global pigmented lesion treatment market is segmented based on lesion type, product type, end user and region.
The lasers and energy based devices segment accounted for approximately 62.5% of the market share
The lasers and energy-based devices segment is expected to hold the largest market share over the period forecast due to the increasing number of product approvals. Lasers and energy-based devices are widely used in dermatology and cosmetic procedures for various skin treatments. RF energy is used to heat the skin's deeper layers, promoting collagen remodeling and improving skin tightness.
For instance, in 2022, LASEROPTEK Co., Ltd. received U.S. Food and Drug Administration 510(k) clearance for its HELIOS IV-785 laser system for use in dermatology and general surgery. It is used to treat skin toning, brightening, benign pigmented and vascular lesion removal, and multi-color tattoo eradication.
Additionally, in March 2023, The US Food and Drug Administration (FDA) cleared Candela Corporation’s PicoWay laser for the treatment of café au lait, lentigines, and melasma. the laser system has been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkles. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global pigmented lesion treatment market share
The global pigmented lesion treatment market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising aesthetic surgical procedures, increasing prevalence of pigmentation disorders, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Aesthetics Society, aesthetic surgical procedures increased 54% and non-surgical procedures were up 44%. The average plastic surgeon performed 320 surgical procedures in 2021 in the United States.
Additionally, according to the National Institute of Health, the population-based prevalence estimate of overall vitiligo in adults is between 0.76% (1.9 million cases) and 1.11% (2.8 million cases). Also, the study suggests that approximately 40% of adult vitiligo in the U.S. may be undiagnosed.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global pigmented lesion treatment market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatment, drug launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the pigmented lesion treatment market is expected to be moderately affected over the forecast period.
Market Segmentation
By Lesion Type
• Freckles
• Lentigines
• Melasma
• Others
By Product Type
• Lasers and Energy Based Devices
• RF Devices
• Ultrasound Devices
• Others
By End User
• Dermatology Clinics
• Hospitals
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Alma Lasers Ltd, Cutera Inc., Cynosure Inc., Lumenis Be Ltd., Lutronic Corporation, Lynton Lasers Ltd, Bausch Health, Fotona, Asclepion Laser Technologies, Candela Corporation among others.
Key Developments
• In April 2021, Cynosure acquired the MyEllevate Surgical Suture System, expanding the Company's portfolio of minimally invasive facial rejuvenation solutions.
Why Purchase the Report?
• To visualize the global pigmented lesion treatment market segmentation based on lesion type, product type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global pigmented lesion treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pigmented lesion treatment market report would provide approximately 58 tables, 58 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Lesion Type
3.2. Snippet by Product Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing product launches
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Side effects associated with laser treatments
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Lesion Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
7.1.2. Market Attractiveness Index, By Lesion Type
7.2. Freckles*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Lentigines
7.4. Melasma
7.5. Others
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Lasers and Energy Based Devices*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. RF Devices
8.4. Ultrasound Devices
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Dermatology Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Alma Lasers Ltd.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Cutera Inc.
12.3. Cynosure Inc.
12.4. Lumenis Be Ltd.
12.5. Lutronic Corporation
12.6. Lynton Lasers Ltd
12.7. Bausch Health
12.8. Fotona
12.9. Asclepion Laser Technologies
12.10. Candela Corporation
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Alma Lasers Ltd., 4.	Key Developments, Cutera Inc., Cynosure Inc., Lumenis Be Ltd., Lutronic Corporation, Lynton Lasers Ltd, Bausch Health, Fotona, Asclepion Laser Technologies, Candela Corporation

표 목록 (Tables)

List of Tables

Table 1 Global Pigmented Lesion Treatment Market Value, By Lesion Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Pigmented Lesion Treatment Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Pigmented Lesion Treatment Market Value, By End User , 2023, 2027 & 2031 (US$ Million)

Table 4 Global Pigmented Lesion Treatment Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Pigmented Lesion Treatment Market Value, By Lesion Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 7 Global Pigmented Lesion Treatment Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 9 Global Pigmented Lesion Treatment Market Value, By End User , 2023, 2027 & 2031 (US$ Million)

Table 10 Global Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 11 Global Pigmented Lesion Treatment Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Pigmented Lesion Treatment Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 14 North America Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 15 North America Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 16 North America Pigmented Lesion Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 18 South America Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 19 South America Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 20 South America Pigmented Lesion Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 22 Europe Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 23 Europe Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 24 Europe Pigmented Lesion Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 28 Asia-Pacific Pigmented Lesion Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Pigmented Lesion Treatment Market Value, By Lesion Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Pigmented Lesion Treatment Market Value, By Product Type, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Pigmented Lesion Treatment Market Value, By End User , 2022-2031 (US$ Million)

Table 32 Alma Lasers Ltd: Overview

Table 33 Alma Lasers Ltd: Product Portfolio

Table 34 Alma Lasers Ltd: Key Developments

Table 35 Cutera Inc.: Overview

Table 36 Cutera Inc.: Product Portfolio

Table 37 Cutera Inc.: Key Developments

Table 38 Cynosure Inc.: Overview

Table 39 Cynosure Inc.: Product Portfolio

Table 40 Cynosure Inc.: Key Developments

Table 41 Lumenis Be Ltd. : Overview

Table 42 Lumenis Be Ltd. : Product Portfolio

Table 43 Lumenis Be Ltd. : Key Developments

Table 44 Lutronic Corporation: Overview

Table 45 Lutronic Corporation: Product Portfolio

Table 46 Lutronic Corporation: Key Developments

Table 47 Lynton Lasers Ltd: Overview

Table 48 Lynton Lasers Ltd: Product Portfolio

Table 49 Lynton Lasers Ltd: Key Developments

Table 50 Bausch Health : Overview

Table 51 Bausch Health : Product Portfolio

Table 52 Bausch Health : Key Developments

Table 53 Fotona: Overview

Table 54 Fotona: Product Portfolio

Table 55 Fotona: Key Developments

Table 56 Asclepion Laser Technologies: Overview

Table 57 Asclepion Laser Technologies: Product Portfolio

Table 58 Asclepion Laser Technologies: Key Developments

Table 59 Candela Corporation: Overview

Table 60 Candela Corporation: Product Portfolio

Table 61 Candela Corporation: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 2 Global Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 3 Global Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 4 Global Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 5 Global Pigmented Lesion Treatment Market Share, By Region, 2023 & 2031 (%)

Figure 6 Global Pigmented Lesion Treatment Market Y-o-Y Growth, By Lesion Type, 2023-2031 (%)

Figure 7 Freckles Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 8 Lentigines Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 9 Melasma Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 10 Others Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 11 Global Pigmented Lesion Treatment Market Y-o-Y Growth, By Product Type, 2023-2031 (%)

Figure 12 Lasers and Energy Based Devices Product Type in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 13 RF Devices Product Type in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 14 Ultrasound Devices Product Type in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 15 Others Product Type in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 16 Global Pigmented Lesion Treatment Market Y-o-Y Growth, By End User , 2023-2031 (%)

Figure 17 Dermatology Clinics End User in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 18 Hospitals End User in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 19 Others End User in Global Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 20 Global Pigmented Lesion Treatment Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 21 North America Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 22 Asia-Pacific Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 23 Europe Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 24 South America Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 25 Middle East and Africa Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 26 North America Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 27 North America Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 28 North America Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 29 North America Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 30 North America Pigmented Lesion Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 31 South America Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 32 South America Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 33 South America Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 34 South America Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 35 South America Pigmented Lesion Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 36 Europe Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 37 Europe Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 38 Europe Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 39 Europe Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 40 Europe Pigmented Lesion Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 41 Asia-Pacific Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 42 Asia-Pacific Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 43 Asia-Pacific Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 44 Asia-Pacific Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 45 Asia-Pacific Pigmented Lesion Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 46 Middle East & Africa Pigmented Lesion Treatment Market Value, 2022-2031 (US$ Million)

Figure 47 Middle East & Africa Pigmented Lesion Treatment Market Share, By Lesion Type, 2023 & 2031 (%)

Figure 48 Middle East & Africa Pigmented Lesion Treatment Market Share, By Product Type, 2023 & 2031 (%)

Figure 49 Middle East & Africa Pigmented Lesion Treatment Market Share, By End User , 2023 & 2031 (%)

Figure 50 Alma Lasers Ltd: Financials

Figure 51 Cutera Inc.: Financials

Figure 52 Cynosure Inc.: Financials

Figure 53 Lumenis Be Ltd. : Financials

Figure 54 Lutronic Corporation: Financials

Figure 55 Lynton Lasers Ltd: Financials

Figure 56 Bausch Health : Financials

Figure 57 Fotona: Financials

Figure 58 Asclepion Laser Technologies: Financials

Figure 59 Candela Corporation: Financials

세계 색소성 병변 치료 시장 – 2023-2030

Global Pigmented Lesion Treatment Market - 2023-2030